Physicians continue to decline as the target customer base for industry marketing, according to survey repondents
In its third annual Pharma Insights study, a survey of commercial and executive management among pharma, biotech and generic manufacturers, Cegedim Relationship Management (Bedminster, NJ) finds an intensification of trends that began last year: a growing emphasis on managed care; a rising importance of IT and communication platforms (especially mobile devices); and greater interest in social media as both an external and internal communication channel. Overall, the dominant factor remains “the changing commercial model”, ranked first by 74% of respondents. “Respondents report strong focus on business model changes, as well as next generation and mobile technologies,” said Angela Miccoli, president of the company’s North America unit.
The decline of physicians as the primary customers of pharma marketing efforts continues: this year counted them as 28% of the primary audience, versus last year's 42%. “Government” and “managed care” together equal physicians in 2012; patients represent 10% of the primary customers. (Interestingly, the largest category of audience, at 34%, is “other”—which likely ranges from pharmacy directors to PBMs, GPOs, wholesalers and others in the pharma supply chain.)
Deciding how to invest in information technology has become a higher-level executive decision, according to Cegedim. “Executive management” is now the primary driver of new technology investment among 46% of respondents, as compared to 28% last year. Business units, IT management, regulatory compliance and others all fall behind.
The trend toward mobile technologies—interactive tablets and smartphones—is inescapabale, and the Cegedim survey reflects this. One interesting result is that while 50% of respondents are, or plan to, be using the Apple OS platform, 30% plan to use Microsoft Windows, ahead of the Google Android. (This result might reflect picking up usage of Windows-based tablets and laptops that precede the iPad wave of the past couple years; just recently Microsoft released both a new mobile platform and hardware to go with it.)
The full survey is available from Cegedim.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.